Last reviewed · How we verify
Blood sample at D1, D3 and D7 — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Blood sample at D1, D3 and D7 (Blood sample at D1, D3 and D7) — Assistance Publique - Hôpitaux de Paris.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Blood sample at D1, D3 and D7 TARGET | Blood sample at D1, D3 and D7 | Assistance Publique - Hôpitaux de Paris | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Blood sample at D1, D3 and D7 CI watch — RSS
- Blood sample at D1, D3 and D7 CI watch — Atom
- Blood sample at D1, D3 and D7 CI watch — JSON
- Blood sample at D1, D3 and D7 alone — RSS
Cite this brief
Drug Landscape (2026). Blood sample at D1, D3 and D7 — Competitive Intelligence Brief. https://druglandscape.com/ci/blood-sample-at-d1-d3-and-d7. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab